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Individuals with neonatal progeroid syndrome don’t
have premature aging, but they appear aged, partly
because of reduced levels of subcutaneous fat. Unexpect-
edly, when Romere et al. went on a hunt for causative
mutations, they found de novo truncating variants in
FBN1, better known as the gene associated with
Marfan syndrome. This surprise led the authors down a
path to discovery of a new hormone, dubbed asprosin,
which is a C-terminal cleavage product of profibrillin
and is found at very low levels in individuals with
neonatal progeroid syndrome. Asprosin is secreted by
adipose tissue into the plasma and causes the liver
to release glucose. Fasting triggers asprosin elevation.
Beyond being relevant to the rare progeroid syndrome,
asprosin levels are abnormally elevated in individuals
with the much more common phenotype of insulin
resistance. In mouse models of insulin resistance, using
antibodies to block asprosin lowers glucose and insulin
levels, suggesting a new therapeutic target for type II
diabetes.
Romere et al. (2016). Cell. Published online April 14, 2016.
http://dx.doi.org/10.1016/j.cell.2016.02.063.Observations of Imprinted Gene Expression at the
Single-Cell Level
Imprinted genes exhibit preferential expression from one
of the two parental alleles. When this preference is not
properly maintained, imprinting disorders arise. One
outstanding question is whether this inappropriate gene
expression happens in all cells or only in a subset. To
address this question, Ginart et al. made use of a new
technique, SNP fluorescence in situ hybridization (FISH),
in which transcripts from a gene of interest are tagged
with a FISH probe, and then the two alleles are
distinguished with a second set of probes that are
complementary to one or the other parental allele. The
authors applied SNP FISH to study the H19-Igf2 locus.
Normally, H19 is maternally expressed, but when the
imprinting center in the region is defective, expression
occurs from both parental alleles. SNP FISH revealed
that this biallelic expression actually occurs in only a1Department of Human Genetics, Emory University School of Medicine, Atlan
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proper maternal H19 expression. Once the expression
pattern is set, whether monoallelic or biallelic, it is
heritable for several cellular generations and is dictated
by methylation at the imprinting center. Further explora-
tion of this cell-to-cell heterogeneity might help explain
the asymmetry observed in patients with relevant
imprinting disorders.
Ginart et al. (2016). Genes Dev. 30, 567–578.Lnc-ing a Haplotype to Celiac Disease
Intrigued by the association between apparently noncod-
ing genomic regions and human disease, Castellanos-
Rubio et al. explored the role of one such haplotype
block in the development of celiac disease. Although the
haplotype was outside a protein-coding gene, the re-
searchers noted that a long-noncoding RNA (lncRNA)
had been reported in the orthologous region in mice.
With further digging into the human region, they discov-
ered lnc13, a lncRNA that works in conjunction with
hnRNPD to regulate the expression of genes involved in
inflammation. When it contains the haplotype of celiac-
associated alleles, lnc13 binds less well to hnRNPD, which
would be predicted to increase expression of these inflam-
mation genes, providing an intriguing potential link (or
should I say lnc?) between the haplotype and celiac
disease.
Castellanos-Rubio et al. (2016). Science 352, 91–95.Too Much or Too Little
When copy-number variation (CNV) results from non-
allelic homologous recombination, CNVs of the same
size and opposite doses can occur repeatedly, leading to
loss or gain of copies of the same genes in different peo-
ple. Although recurrent, each CNV is still relatively rare,
which impedes our understanding of them. One way to
appreciate their impact is to ascertain individuals with a
particular genetic variant through clinical testing, but
this is an inherently biased view, particularly given that
the only information you might have about the individ-
ual is the phenotype provided on the test requisition.ta, GA 30322, USA
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The Simons VIP Consortium aims to have a more com-
plete picture of certain CNVs through broad proband
recruitment followed by cascade testing in families.
Standardized assessments are then used for evaluating car-
rier and non-carrier family members. This consortium
recently completed their work describing the deletion
and its reciprocal duplication at chromosomal region
1q21.1. For some phenotypes, having too much or too
little of the 1q21 region yields a similar outcome: both
variants are associated with hypotonia, motor impair-
ment, and articulation issues, as well as decreased cogni-
tive function. Other phenotypes are opposite between
the two dosages, namely microcephaly in deletion carriers
and macrocephaly in duplication carriers. And finally,
some phenotypes are more severe in one group than in
the other. Although we typically think of cytogenetic de-
letions as being more deleterious, the Simons cohort
suggests that the 1q21.1 duplication is more likely to be
associated with autism spectrum disorder and with greater
deficits in verbal cognitive ability. This approach to collec-
tion and assessment of individuals further refines our
understanding of CNV at 1q21.1.
Bernier et al. (2016). Genet. Med. 18, 341–349.800 The American Journal of Human Genetics 98, 799–800, May 5, 2Expanding the Spectrum of Disease Due to PIK3CA
Mutations
Activating mutations in PIK3CA occur in a variety of can-
cers, but somatic variation in this gene is also responsible
for a range of non-cancerous overgrowth phenotypes,
including megalencephaly-capillary malformation syn-
drome and fibroadipose hyperplasia. Two recent papers
in Science Translational Medicine expand this spectrum to
include venous malformations. In separate cohorts of
affected individuals, both groups identified activating so-
matic PIK3CA mutations in about one-quarter. The only
other gene known to contain mutations responsible for
venous malformations is TEK, which encodes a receptor
that lies upstream of PI3K in the PI3K-AKT signaling
pathway, thereby coalescing the pathogenic mechanism
to this pathway and suggesting that its inhibition might
be a treatment strategy. Both groups used mouse models
of Pik3ca-based venous malformations to implicate endo-
thelial cells as central to their pathogenesis and demon-
strate the potential of PI3K-AKT inhibition as a therapy.
Castel et al. (2016). Sci. Transl. Med. 8, 332ra42.
Castillo et al. (2016). Sci. Transl. Med. 8, 332ra43.This Month in Our Sister JournalsBlurred Lines
The pseudoautosomal regions (PARs) at the ends of the sex
chromosomes are homologous regions that can pair and
recombine during male meiosis. Unlike most other regions
of the X chromosome, genes in the PARs are not silenced
via X inactivation in females, given that most people,
regardless of gender, have two copies of each of these
genes. Because they can recombine, the PARs should
have higher genetic diversity than the rest of the sex chro-
mosomes. In fact, the PAR sequences are often tossed out
of population genetic studies because they are not ex-pected to behave like the rest of the sex chromosomes.
To see whether this prediction, in fact, holds true, Cotter
et al. explored genetic diversity across the X chromosome
in females. Their analysis suggests that some X regions
behave differently than assumed. They found that genetic
diversity in the two PARs is not equal, nor is genetic diver-
sity across the non-PAR X constant. This finding affects our
understanding of the behavior of different X regions, and
it could also have an impact on the design of future popu-
lation genetic studies that include the X chromosome.
Cotter et al. (2016). Genetics. Published online April 2, 2016.
http://dx.doi.org/10.1534/genetics.114.172692.016
